HOME >> MEDICINE >> NEWS
Recurrent miscarriage project update

In response to speculation in a national newspaper, listed biopharmaceutical company GroPep Limited (ASX: GRO) announced today that ethics committee approval has been received to conduct a clinical research study as part of the ongoing development of its Recurrent Miscarriage project (PV903). The ethics approval is subject to a number of conditions.

The study aims to characterise immune cell populations from the cervix of healthy women as a basis for further studies that will investigate the effect of PV903 in a Phase I clinical trial, planned for 2006.

GroPep will continue to keep the market updated as further information becomes available on the status of the PV903 project.

GroPep is a world leader in the development, manufacture and commercialisation of biologically active proteins for cell culture and biomedical research. The Company has an active biopharmaceutical development program that establishes proof of concept for products in humans and partners the later stages of product development and marketing with major pharmaceutical companies. GroPep is listed on the Australian Stock Exchange Limited (ASX code: GRO).


'"/>

Contact: Tony Mitchell
investorrelations@gropep.com.au
61-883-547-700
Research Australia
14-Jul-2005


Page: 1

Related medicine news :

1. Recurrent melanoma may be more common than previously thought
2. Underweight women at greater risk of miscarriage
3. Easing the anxiety of pregnancy after miscarriage
4. Test project of patient-centered medical home model endorsed by American College of Physicians
5. Spanish project AmIVital creates intelligent communication devices for elderly and disabled people
6. Healthy schools project gets an A
7. New project to analyze why Polycystic Ovary Syndrome and insulin resistance are so closely linked
8. Liverpool launches 20 million project to develop medicines for children
9. New family health history projects focus on Alaska Native, Appalachian communities
10. ESSP launches project on the effects of global environmental change on human health
11. Global Environmental Change and Human Health: New project launched at GEC Conference in Beijing

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Recurrent miscarriage project update

(Date:5/23/2013)... 2013 Greenville Oral & Maxillofacial ... members and doctors have recently completed their bi-annual ... an Automated External Defibrillator (AED). ... medical device designed to analyze the heart rhythm ... ventricular fibrillation to restore the heart rhythm to ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Great defined abs ... what almost everyone strives to achieve in the gym yet ... crunches will not make this goal become a reality. Great ... that are often time overlooked. Scott Tischler of Tischler Brothers ... done to achieve the goal of great abs. , 1.    Go ...
(Date:5/23/2013)... PhD Box has introduced a service that ... process by offering assistance for Thesis Proposals. The proposal writing ... that the company provides for research consultation in various fields. ... writing service is that this is the stage where most ... find it difficult to draft a proposal as it is ...
(Date:5/23/2013)... Fredericton, NB (PRWEB) May 23, 2013 ... contact center software for Asterisk telephony, ... a self-regulating Automatic Monitoring and Decision Making System ... High Availability and offer call survival. The new ... self-regulating overseer mechanism, thereby enhancing reliability. , Large ...
(Date:5/23/2013)... May 23, 2013 Long-Term Care Insurance ... in the rate at which applicants for Long Term Care ... coverage. , The decision to buy a Long ... even consumers willing and able to purchase protection are increasingly ... policy at any price. A variety of chronic conditions ...
Breaking Medicine News(10 mins):Health News:Greenville Oral & Maxillofacial Surgeons Announce CPR Re-Certification 2Health News:Scott Tischler of Tischler Brothers Fitness Unveils the 4 Secrets to Getting Abs this Summer 2Health News:PhD Box Unveils Proposal Writing Services for Research Scholars 2Health News:Indosoft Upgrades its Overseer Watchdog System for Q-Suite to Enhance High Availability with Call Survival for Mission Critical ACD Applications 2Health News:More Baby Boomers Rejected by Long Term Care Insurance Companies 2Health News:More Baby Boomers Rejected by Long Term Care Insurance Companies 3
(Date:5/23/2013)... and DRESDEN, Germany , ... BioScience, a leading preclinical contract research provider and ... content-driven pharmacology, and Debiopharm Group™ (Debiopharm), a Swiss-based ... on the development of prescription drugs that target ... today announced that they have signed a research ...
(Date:5/22/2013)... 22, 2013  Aribex, Inc., manufacturer of the newly ... a new color option, black with gray trim, of ... veterinary markets. The popular white with light blue trim ... to be available and both models can be purchased ... (Photo: http://photos.prnewswire.com/prnh/20130522/CL19573 ) "Dental offices are ...
(Date:5/22/2013)... 22, 2013 Advanced Prenatal Therapeutics (APT), a ... will help alleviate the high blood pressure and other ... expected to be the first medical device specifically designed ... fetal death. Every year, preeclampsia affects approximately ... . It is characterized by high blood pressure ...
Breaking Medicine Technology:Cenix BioScience and Debiopharm Group Collaborate to Identify Predictive Biomarkers 2Cenix BioScience and Debiopharm Group Collaborate to Identify Predictive Biomarkers 3Cenix BioScience and Debiopharm Group Collaborate to Identify Predictive Biomarkers 4Aribex Unveils New Color of NOMAD Pro 2 2Advanced Prenatal Therapeutics - Using Targeted Apheresis to Treat Preeclampsia 2
Cached News: